JFL Life Sciences (NSE:JFLLIFE) Research & Development: ₹0.0 Mil (TTM As of Mar. 2025)


NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
65 GF Score
Price ₹9.05
GF Value ₹35.55
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences Research & Development?

JFL Life Sciences NSE:JFLLIFE 65 Research & Development is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 65/100 and a GF Value™ of ₹35.55 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. JFL Life Sciences's Research & Development for the six months ended in Mar. 2025 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

JFL Life Sciences  (NSE:JFLLIFE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JFL Life Sciences Research & Development Related Terms

JFL Life Sciences Research & Development Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Research & Development Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:JFLLIFE
65GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
JFL Life Sciences (NSE:JFLLIFE) has a Research & Development of ₹0.0 Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on JFL Life Sciences and its competitors.
Is JFL Life Sciences' Research & Development too high?
JFL Life Sciences' current Research & Development is ₹0.0 Mil. Overall, JFL Life Sciences has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Research & Development compare to ZTS and UTHR?
JFL Life Sciences' Research & Development of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on JFL Life Sciences and its competitors. JFL Life Sciences's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.55, compared to a current price of ₹9.05 — trading 74.5% below its estimated fair value. The current Research & Development is ₹0.0 Mil. JFL Life Sciences' overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Research & Development is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.05 is trading 74.5% below its estimated GF Value™ of ₹35.55. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹35.55 vs. price of ₹9.05 (74.5% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
65GF Score

Get the complete analysis for NSE:JFLLIFE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.05
Price
₹35.55
GF Value